The Lung Cancer Channel is supported with funding from Johnson & Johnson (Gold) and Takeda (Gold).
VJOncology is an independent medical education platform. Supporters, including channel supporters, have no influence over the production of content. The levels of sponsorship listed are reflective of the amount of funding given to support the channel.
BTOG 2023 | RAPID-RT: dose-limited cardio-radiotherapy for NSCLC
Corinne Faivre-Finn, FRCR, MD, PhD, The University of Manchester, Manchester, UK & The Christie NHS, Manchester, UK, discusses the real-world RAPID-RT study, which introduced a dose-limit to the base of the heart for patients with non-small cell lung cancer who were undergoing radical radiotherapy, with the aim of improving survival. This interview took place at the British Thoracic Oncology Group (BTOG) Annual Conference 2023 in Belfast, UK.
These works are owned by Magdalen Medical Publishing (MMP) and are protected by copyright laws and treaties around the world. All rights are reserved.
Disclosures
None
